Commitment towards creating consistent value for our shareholders
Clarification on news item appearing in https:www.ndtvprofit.com
Press Release - Acrotech Biopharma Inc., Announces FDA Approval of ADQUEYTM difamilast 1 Ointment
Completion of US FDA Inspection at Unit-VII of Aurobindo Pharma Limited, Jedcherla
Outcome of Board Meeting 09.02.2026
Completion of US FDA Inspection at Unit-III of Eugia Pharma Specialities Limited
Clarification on Significant Volume Movement in Companys Shares
Incorporation of a new wholly owned step-down subsidiary in Philippines
CuraTeQ Biologics receives NOC from Health Canada for its biosimilar Dyrupeg
Acquisition of the branded non-oncology prescription formulations business of Khandelwal Laboratories Pvt.Ltd., by Auro Pharma Limited